#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Paul Levesque Email
President and CEO . Theratechnologies
Montreal, QC
LocationPrimary Email
How to contact Paul Levesque
Join and see Paul's contact info for free!Current Roles
Employees:
238Revenue:
$47.8MAbout
Theratechnologies (TSX: TH) is a specialty pharmaceutical Corporation that discovers and develops innovative therapeutic peptide products, with an emphasis on growth-hormone releasing factor (GRF) peptides. Theratechnologies' strategy is to leverage its expertise in the field of metabolism and GRF peptides to address serious health disorders while remaining actively involved in the commercialization of its future products. Its first product, EGRIFTA (tesamorelin for injection), was approved by the United States Food and Drug Administration in November 2010. To date, EGRIFTA is the only approved therapy for the reduction of excess abdominal fat in people living with HIV.Theratechnologies Address
101 Hudson StreetMontreal, QC
CAN